Impetigo: A Reassessment of Etiology and Therapy
- 1 November 1987
- journal article
- clinical trial
- Published by Wiley in Pediatric Dermatology
- Vol. 4 (3) , 185-188
- https://doi.org/10.1111/j.1525-1470.1987.tb00776.x
Abstract
Traditional concepts regarding the bacteriology and therapy of nonbullous impetigo have been reexamined. Although in the United States the disease is considered primarily of streptococcal origin and amenable to penicillin therapy, we found that Staphylococcus aureus was the most common isolate in 71 patients studied. Only two patients yielded pure cultures of group A beta-hemolytic streptococci. All but two isolates of S. aureus were resistant to penicillin; one of these two isolates was also resistant to erythromycin. Erythromycin appeared to be more efficacious than penicillin for the treatment of impetigo.Keywords
This publication has 16 references indexed in Scilit:
- ImpetigoPediatrics in Review, 1985
- Practical Aspects of Bacterial Skin Infections in ChildrenPediatric Dermatology, 1985
- Topical and Systemic Therapy for PyodermasInternational Journal of Dermatology, 1980
- Natural history of impetigoJournal of Clinical Investigation, 1972
- Natural history of impetigoJournal of Clinical Investigation, 1972
- Further studies on the treatment of streptococcal skin infectionThe Journal of Pediatrics, 1970
- The treatment of pyoderma in childrenPublished by American Medical Association (AMA) ,1970
- The treatment of streptococcal skin infectionsThe Journal of Pediatrics, 1970
- Impetigo ContagiosaAmerican Journal of Diseases of Children, 1967
- The Route of Antibiotic Administration in Superficial ImpetigoNew England Journal of Medicine, 1963